Therefore, the aim of this study was to investigate the contribution of CD226 sequence variants to susceptibility to type 1 diabetes in our population and to correlate risk variants with clinical data, autoantibody status, C peptide levels, and HLA (DR) alleles. This evidence concerns the gene CD226 and type 1 diabetes mellitus.